RxDoctor Payments Data

Laura Schanberg

Rheumatology · Durham, NCNPI 1558424333

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $16,762 of the $20,150 with a category attached, or 83.2%. 7 manufacturers reported payments, led by Sanofi US Services Inc. at 34.6% of the total.

$20,150in general payments, 2019–2025

Across 24 payments — averaging $839.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi US Services Inc.$7K
  • UCB SA$6K
  • E.r. Squibb & Sons, L.L.C.$5K
  • UCB GmbH$2K
  • Swedish Orphan Biovitrum AB$467
  • UCB Biosciences Inc.$26
  • plus $24 from 1 others
$6,871,755in research payments, 2019–2025

Across 14 payments — averaging $490,840 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Roche Products Limited$5M
  • Pfizer$1.4M
  • E.r. Squibb & Sons, L.L.C.$273K
  • Fresenius Kabi USA, LLC$161K

What the payments were for

  • Consulting fees$16,76283%
  • Speaking & faculty fees$3,23216%
  • Food & beverage$1561%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,150 in reported general payments places this provider in the 85th percentile of 210 rheumatology providers in North Carolina.

See all rheumatology providers in North Carolina

Other rheumatology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →